List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Influenza Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Trivalent Flu Vaccines
1.4.3 Quadrivalent Flu Vaccines
1.5 Market by Application
1.5.1 Global Influenza Vaccines Market Share by Application: 2022-2027
1.5.2 Adults
1.5.3 Pediatrics
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Influenza Vaccines Market
1.8.1 Global Influenza Vaccines Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Influenza Vaccines Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Influenza Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Influenza Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Influenza Vaccines Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Influenza Vaccines Sales Volume Market Share by Region (2016-2021)
3.2 Global Influenza Vaccines Sales Revenue Market Share by Region (2016-2021)
3.3 North America Influenza Vaccines Sales Volume
3.3.1 North America Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.3.2 North America Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Influenza Vaccines Sales Volume
3.4.1 East Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Influenza Vaccines Sales Volume (2016-2021)
3.5.1 Europe Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Influenza Vaccines Sales Volume (2016-2021)
3.6.1 South Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Influenza Vaccines Sales Volume (2016-2021)
3.7.1 Southeast Asia Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Influenza Vaccines Sales Volume (2016-2021)
3.8.1 Middle East Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Influenza Vaccines Sales Volume (2016-2021)
3.9.1 Africa Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Influenza Vaccines Sales Volume (2016-2021)
3.10.1 Oceania Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Influenza Vaccines Sales Volume (2016-2021)
3.11.1 South America Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.11.2 South America Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Influenza Vaccines Sales Volume (2016-2021)
3.12.1 Rest of the World Influenza Vaccines Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Influenza Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Influenza Vaccines Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Influenza Vaccines Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Influenza Vaccines Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Influenza Vaccines Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Influenza Vaccines Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Influenza Vaccines Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Influenza Vaccines Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Influenza Vaccines Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Influenza Vaccines Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Influenza Vaccines Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Influenza Vaccines Sales Volume Market Share by Type (2016-2021)
14.2 Global Influenza Vaccines Sales Revenue Market Share by Type (2016-2021)
14.3 Global Influenza Vaccines Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Influenza Vaccines Consumption Volume by Application (2016-2021)
15.2 Global Influenza Vaccines Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Influenza Vaccines Business
16.1 AstraZeneca
16.1.1 AstraZeneca Company Profile
16.1.2 AstraZeneca Influenza Vaccines Product Specification
16.1.3 AstraZeneca Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 CSL
16.2.1 CSL Company Profile
16.2.2 CSL Influenza Vaccines Product Specification
16.2.3 CSL Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 GlaxoSmithKline
16.3.1 GlaxoSmithKline Company Profile
16.3.2 GlaxoSmithKline Influenza Vaccines Product Specification
16.3.3 GlaxoSmithKline Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Sanofi
16.4.1 Sanofi Company Profile
16.4.2 Sanofi Influenza Vaccines Product Specification
16.4.3 Sanofi Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Altimmune
16.5.1 Altimmune Company Profile
16.5.2 Altimmune Influenza Vaccines Product Specification
16.5.3 Altimmune Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 BionVax
16.6.1 BionVax Company Profile
16.6.2 BionVax Influenza Vaccines Product Specification
16.6.3 BionVax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 FluGen
16.7.1 FluGen Company Profile
16.7.2 FluGen Influenza Vaccines Product Specification
16.7.3 FluGen Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 FOLIA BIOTECH
16.8.1 FOLIA BIOTECH Company Profile
16.8.2 FOLIA BIOTECH Influenza Vaccines Product Specification
16.8.3 FOLIA BIOTECH Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Genentech
16.9.1 Genentech Company Profile
16.9.2 Genentech Influenza Vaccines Product Specification
16.9.3 Genentech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Green Cross
16.10.1 Green Cross Company Profile
16.10.2 Green Cross Influenza Vaccines Product Specification
16.10.3 Green Cross Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Medicago
16.11.1 Medicago Company Profile
16.11.2 Medicago Influenza Vaccines Product Specification
16.11.3 Medicago Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Moderna Therapeutics
16.12.1 Moderna Therapeutics Company Profile
16.12.2 Moderna Therapeutics Influenza Vaccines Product Specification
16.12.3 Moderna Therapeutics Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Novavax
16.13.1 Novavax Company Profile
16.13.2 Novavax Influenza Vaccines Product Specification
16.13.3 Novavax Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Shijiazhuang Yiling Pharmaceutical
16.14.1 Shijiazhuang Yiling Pharmaceutical Company Profile
16.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Specification
16.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 SK Chemicals
16.15.1 SK Chemicals Company Profile
16.15.2 SK Chemicals Influenza Vaccines Product Specification
16.15.3 SK Chemicals Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 UNM Pharma
16.16.1 UNM Pharma Company Profile
16.16.2 UNM Pharma Influenza Vaccines Product Specification
16.16.3 UNM Pharma Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Vaccitech
16.17.1 Vaccitech Company Profile
16.17.2 Vaccitech Influenza Vaccines Product Specification
16.17.3 Vaccitech Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Vaxart
16.18.1 Vaxart Company Profile
16.18.2 Vaxart Influenza Vaccines Product Specification
16.18.3 Vaxart Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Vaxine Pty
16.19.1 Vaxine Pty Company Profile
16.19.2 Vaxine Pty Influenza Vaccines Product Specification
16.19.3 Vaxine Pty Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.20 Visterra
16.20.1 Visterra Company Profile
16.20.2 Visterra Influenza Vaccines Product Specification
16.20.3 Visterra Influenza Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Influenza Vaccines Manufacturing Cost Analysis
17.1 Influenza Vaccines Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Influenza Vaccines
17.4 Influenza Vaccines Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Influenza Vaccines Distributors List
18.3 Influenza Vaccines Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Influenza Vaccines (2022-2027)
20.2 Global Forecasted Revenue of Influenza Vaccines (2022-2027)
20.3 Global Forecasted Price of Influenza Vaccines (2016-2027)
20.4 Global Forecasted Production of Influenza Vaccines by Region (2022-2027)
20.4.1 North America Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.3 Europe Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.7 Africa Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.9 South America Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Influenza Vaccines Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Influenza Vaccines by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Influenza Vaccines by Country
21.2 East Asia Market Forecasted Consumption of Influenza Vaccines by Country
21.3 Europe Market Forecasted Consumption of Influenza Vaccines by Countriy
21.4 South Asia Forecasted Consumption of Influenza Vaccines by Country
21.5 Southeast Asia Forecasted Consumption of Influenza Vaccines by Country
21.6 Middle East Forecasted Consumption of Influenza Vaccines by Country
21.7 Africa Forecasted Consumption of Influenza Vaccines by Country
21.8 Oceania Forecasted Consumption of Influenza Vaccines by Country
21.9 South America Forecasted Consumption of Influenza Vaccines by Country
21.10 Rest of the world Forecasted Consumption of Influenza Vaccines by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
